Perspective Therapeutics (CATX) Loans - Net (2022)

Perspective Therapeutics' (CATX) quarterly Loans - Net came in at $6.1 million in Q4 2022.

Perspective Therapeutics (CATX) Loans - Net (2022) Analysis & Trends

Perspective Therapeutics has disclosed Loans - Net across 1 years of filings, most recently posting $6.1 million for Q4 2022.

Loans - Net for Q4 2022 came in at $6.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $6.1 million (changed N/A YoY), and the FY2022 annual result was $6.1 million, changed N/A from the prior year.
Loans - Net came in at $6.1 million for Q4 2022 at Perspective Therapeutics.
In the past five years, Loans - Net ranged from a high of $6.1 million in Q4 2022 to a low of $6.1 million in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Loans (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Perspective Therapeutics	308.74 Mn	308.74 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2022	6.11 Mn
Dec 31, 2022	6.11 Mn